Tag: incobotulinumtoxina

IncobotulinumtoxinA for the Treatment of Glabellar Frown Lines: A Prospective, Multicenter, Single-arm Study in Taiwan

December 1, 2019

Objective: We assessed clinical effectiveness, longevity of treatment effects, and patient satisfaction with incobotulinumtoxinA for glabellar frown lines (GFL) treatment in Asian patients.

Treatment of Lateral Periorbital Lines with Different Dilutions of IncobotulinumtoxinA

September 1, 2017

by Gabriele F. Muti, MD, and Matteo Basso, MD Dr. Muti is with the Department of Plastic Surgery, European Dermatological Institute, in Milan, Italy. Dr. Basso is with the Studio Dermatologico in Rome, Italy. Funding: No funding was provided for this study. Disclosures: Dr. Muti has been an investigator and speaker for Merz Pharmaceuticals GmbH